Dr. Barry Dworkin

Health Canada rightly conducts safety review on off-label prescribing of breastfeeding drug, domperidone, amid psychiatric concerns as well as risk of cardiac arrhythmia. Available in US as investigational drug but banned for general use.

Medical Mythbusting Commentary for February 1, 2023

Source:
Health Canada conducts safety review on breastfeeding drug amid psychiatric concerns

Related posts:

  1. BMJ reports birth control pill use not associated with increased long-term risk of death
  2. Two stories that underlie importance of risk and benefit of using medications
  3. Opiate crisis in Ontario leads to medication updates and increases in support services
  4. New opioid prescribing rules will hep physicians reduce opioid use.